Omnicell Revenue 2012-2026 | OMCL
Omnicell revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Omnicell Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $1,185 |
| 2024 | $1,112 |
| 2023 | $1,147 |
| 2022 | $1,296 |
| 2021 | $1,132 |
| 2020 | $892 |
| 2019 | $897 |
| 2018 | $787 |
| 2017 | $713 |
| 2016 | $696 |
| 2015 | $485 |
| 2014 | $441 |
| 2013 | $381 |
| 2012 | $314 |
| 2011 | $246 |
|
Omnicell Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-03-31 | $310 |
| 2025-12-31 | $314 |
| 2025-09-30 | $311 |
| 2025-06-30 | $291 |
| 2025-03-31 | $270 |
| 2024-12-31 | $307 |
| 2024-09-30 | $282 |
| 2024-06-30 | $277 |
| 2024-03-31 | $246 |
| 2023-12-31 | $259 |
| 2023-09-30 | $299 |
| 2023-06-30 | $299 |
| 2023-03-31 | $291 |
| 2022-12-31 | $298 |
| 2022-09-30 | $348 |
| 2022-06-30 | $331 |
| 2022-03-31 | $319 |
| 2021-12-31 | $311 |
| 2021-09-30 | $296 |
| 2021-06-30 | $273 |
| 2021-03-31 | $252 |
| 2020-12-31 | $249 |
| 2020-09-30 | $214 |
| 2020-06-30 | $200 |
| 2020-03-31 | $230 |
| 2019-12-31 | $248 |
| 2019-09-30 | $229 |
| 2019-06-30 | $217 |
| 2019-03-31 | $203 |
| 2018-12-31 | $212 |
| 2018-09-30 | $204 |
| 2018-06-30 | $189 |
| 2018-03-31 | $183 |
| 2017-12-31 | $196 |
| 2017-09-30 | $187 |
| 2017-06-30 | $181 |
| 2017-03-31 | $149 |
| 2016-12-31 | $175 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $171 |
| 2015-12-31 | $130 |
| 2015-09-30 | $125 |
| 2015-06-30 | $113 |
| 2015-03-31 | $116 |
| 2014-12-31 | $122 |
| 2014-09-30 | $113 |
| 2014-06-30 | $105 |
| 2014-03-31 | $102 |
| 2013-12-31 | $106 |
| 2013-09-30 | $94 |
| 2013-06-30 | $94 |
| 2013-03-31 | $87 |
| 2012-12-31 | $90 |
| 2012-09-30 | $84 |
| 2012-06-30 | $75 |
| 2012-03-31 | $64 |
| 2011-12-31 | $63 |
| 2011-09-30 | $64 |
| 2011-06-30 | $61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.564B | $1.185B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |